Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
10/2007
10/02/2007US7276522 dextrorotatory and levo-rotatory enantiomers; specific to alpha2B adrenergic receptors
10/02/2007US7276521 Muscarinic acetylcholine receptor antagonists
10/02/2007US7276520 Bicyclic piperidine derivatives as melanocortin-4 receptor agonists
10/02/2007US7276516 P-indolyl-, indazolyl- and pyrrolopyridyl-sulfonylbenzamides, e.g., N-(4-Fluoro-benzyl)-4-(3-phenyl-indole-1-sulfonyl)-benzamide; modulators of the Cannabinoid-1 receptor, especially useful for treating obesity
10/02/2007CA2413424C Substituted bicyclic derivatives for the treatment of abnormal cell growth
10/02/2007CA2330756C Indole derivatives and their use for the treatment of malignant and other diseases based on pathological cell proliferation
10/02/2007CA2283242C Pesticidal 1-arylpyrazoles
10/02/2007CA2203417C Bisarylcarbinol derivatives as inhibitors of leukotriene biosynthesis
10/02/2007CA2160912C 3-(het)arylcarboxylic acid derivatives, their preparation and intermediates for their preparation
09/2007
09/27/2007WO2007109334A2 Sip receptor modulating compounds and use thereof
09/27/2007WO2007108292A1 Neurite elongation inducer
09/27/2007WO2007107965A1 Cyclohexyl or piperidinyl carboxamide antibiotic derivatives
09/27/2007WO2007107543A1 Inhibitors of the interaction between mdm2 and p53
09/27/2007WO2007107539A1 Compounds which potentiate ampa receptor and uses thereof in medicine
09/27/2007WO2007107384A2 Soluble adenylate cyclase inhibitors
09/27/2007WO2007107383A1 Indole derivatives as inhibitors of the soluble adenylate cyclase
09/27/2007WO2007085833A3 Pyrimidine derivatives
09/27/2007WO2007022241A3 Novel high affinity quinoline-based kinase ligands
09/27/2007US20070225495 N4-(2,2-Dimethyl-3-oxo-4H-5-pyrid[1,4]oxazin-6-yl)-N2-(3-chloro-4-methoxyphenyl)-5-fluoro-2,4-pyrimidinediamine; signal transduction cascade inhibitor; Fc receptors for IgE (Fc epsilon RI) and IgG (Fc gamma RI) antagonist; autoimmune diseases, antiinflammatory agent; rheumatoid arthritis
09/27/2007US20070225485 Foldable polymers as probes
09/27/2007US20070225352 methyl-[3-(2-nitro-phenylsulfanyl)-1-pyridin-2-ylmethyl-1H-indol-6-yl]-amine, possessing androgenic activity are useful in androgen-related treatments such as male hypogonadism, male and female hormone replacement therapy and male contraception
09/27/2007US20070225340 Phenyl Compounds And Their Use In The Treatment Of Conditions Mediated By The Action Of Pge2 At The Ep1 Receptor
09/27/2007US20070225335 Pyrazole Derivatives for Treating Condit Ions Mediated by Activation of the Adeno Sine A2B or A3 Receptor
09/27/2007US20070225321 2,4-pyrimidinediamine compounds and their uses
09/27/2007US20070225319 Piperidinyl indole and tetrohydropyridinyl indole derivatives and methods of their use
09/27/2007US20070225311 Condensation of 7-t-butoxyiminomethylcamptothecin in position 20 with a cyclopeptide containing the RGD sequence; selective cytotoxic activity on human tumor cell lines; antitumor;
09/27/2007US20070225308 2-Amino Quinazoline Derivative
09/27/2007US20070225296 Arylalkylamine Compound and Process for Preparing the Same
09/27/2007US20070225292 Therapeutic Compounds: Pyridine as Scaffold
09/27/2007US20070225287 Substituted Arylpyrazines
09/27/2007US20070225286 Diseases with abnormal activation of the Abl, BCR-Abl, Bmx, CSK, TrkB, FGFR3, Fes, Lck, B-RAF, C-RAF, MKK6, alpha and beta SAPK2 kinases; antiproliferative; pyrrolo[2,3-d]pyrimidine-7-carboxylic acid [3-phenylcarbamoyl-phenyl]-amides and pyrrolo[3,2-c]pyridine analogs
09/27/2007US20070225284 Inhibitors of soluble adenylate cyclase
09/27/2007US20070225269 Use of (3-(1-(3-Phenyl-Propenyl)-Piperidin-4-Yl)-2,3-Dihydro-Indol-1-Yl)-(Pyridin-4-Yl)-Methanonone Derivatives and Related Compounds as Insecticides
09/27/2007US20070224552 Process for the preparation of novel dyes for use in imaging members
09/27/2007DE102006014324A1 Inhibitoren der löslichen Adenylatzklase Inhibitors of soluble Adenylatzklase
09/27/2007DE102006014320A1 Inhibitoren der löslichen Adenylatzklase Inhibitors of soluble Adenylatzklase
09/27/2007DE102006014319A1 Inhibitoren der löslichen Adenylatzyklase Inhibitors of soluble adenylate cyclase
09/27/2007CA2679980A1 S1p receptor modulating compounds and use thereof
09/27/2007CA2647092A1 Indole derivatives as inhibitors of the soluble adenylate cyclase
09/27/2007CA2646594A1 Soluble adenylate cyclase inhibitors
09/27/2007CA2646585A1 Compounds which potentiate ampa receptor and uses thereof in medicine
09/27/2007CA2645867A1 Substituted gamma lactams as prostaglandin ep2 agonists
09/27/2007CA2644643A1 Inhibitors of the interaction between mdm2 and p53
09/26/2007EP1837330A1 Benzamide inhibitors of the P2X7 receptor
09/26/2007EP1837024A2 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (BVDV) infection and hepatitis C virus (HCV) infection
09/26/2007EP1836196A1 Tricyclic delta-opioid modulators
09/26/2007EP1836194A1 4- (1h-indol-3-yl) -pyrimidin-2-ylamine derivates and their use in therapy
09/26/2007EP1836187A1 1h-indole-3-carboxylic acid derivatives and their use as ppar agonists
09/26/2007EP1836183A2 Spiro derivatives as lipoxygenase inhibitors
09/26/2007EP1836180A2 Sulfonyl pyrrolidines, method for producing the same and their use as drugs
09/26/2007EP1836179A1 Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase
09/26/2007EP1836172A1 5-ht7 receptor antagonists
09/26/2007EP1836163A2 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin
09/26/2007EP1554250B1 Novel lactams and uses thereof
09/26/2007EP1339678B1 Ep4 receptor selective agonists in the treatment of osteoporosis
09/26/2007EP1337150A4 Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-triazin-6-ones, and their use as fungicides and insecticides
09/26/2007EP1302461B1 Tnf-alpha production inhibitors
09/26/2007EP1261585B1 Substituted indole mannich bases
09/26/2007EP1228046B1 Phthalazinone derivatives as pde 4 inhibitors
09/26/2007CN101044139A Cyclopamine analogues and methods of use thereof
09/26/2007CN101044138A Methods for preparing indazole compounds
09/26/2007CN101044137A 2,4-di(aminophenyl)pyrimidine derivatives as plk inhibitors
09/26/2007CN101044122A Methods to manufacture 1,3-dioxolane nucleosides
09/26/2007CN101044121A 4-aminopyrimidine-5-one
09/26/2007CN101044113A Substituted indole compounds, their preparation and use in medicaments
09/26/2007CN101041655A Itraconazole sulphate and composition and preparation method thereof
09/26/2007CN100339376C Nitrogen-containing aromatic ring derivatives
09/26/2007CN100339374C Compounds and methods for modulation of estrogen receptors
09/26/2007CN100339352C 2-and 2,5-substituted phenylketoenols
09/25/2007US7273886 Benzofuran inhibitors of factor VIIa
09/25/2007US7273885 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
09/25/2007US7273863 Benzophenones as inhibitors of reverse transcriptase
09/25/2007US7273862 Aminoalkyl substituted (benzodioxan, benzofuran or benzopyran) derivatives
09/25/2007CA2389766C New indenoindolone derivatives, the procedure for preparing them and the pharmaceutical compounds that contain them
09/25/2007CA2243317C Novel fused pyrrolecarboxamides; a new class of gaba brain receptor ligands
09/25/2007CA2230199C Pyridazin-3-one derivatives, their use as a herbicide, and intermediates for their production
09/20/2007WO2007106705A1 Soluble epoxide hydrolase inhibitors and methods of using same
09/20/2007WO2007105989A2 1-oxo-3-(1h-indole)-3-il-1,2,3,4-tetrahydroisoxynolines, methods for the production thereof, combinatoric library and focused library
09/20/2007WO2007105766A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity
09/20/2007WO2007105751A1 Quinolone derivative or pharmaceutically acceptable salt thereof
09/20/2007WO2007105154A2 Antibiotic compounds
09/20/2007WO2007105058A2 Pyrazole compounds
09/20/2007WO2007105053A2 Tetralines antagonists of the h-3 receptor
09/20/2007WO2007105049A1 Dibenzyl amine derivatives as cetp inhibitors
09/20/2007WO2007104933A1 Chemical compounds
09/20/2007WO2007104783A2 1,4 -di substituted 3-cyano-pyridone derivatives and their use as positive mglur2-recept0r modulators
09/20/2007WO2007104695A1 Quinolin-4-ylhydrazine derivatives as antimalarial agent
09/20/2007WO2007104652A2 Non-peptidic renin inhibitors nitroderivatives
09/20/2007WO2007089768A3 4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as jak-2 modulators and pharmaceutical compositions containing them
09/20/2007WO2007087518A3 2-substituted benzimidazoles as selective androgen receptor modulators (sarms)
09/20/2007WO2007085557A3 Use of substituted 2-imidazole of imidazoline derivatives
09/20/2007WO2007071396A8 Pyrazinoylguanidine compounds useful in the treatment of inflammatory or allergic conditions
09/20/2007WO2006017384A3 Indazoles useful in treating cardiovascular diseases
09/20/2007WO2005030712A3 Thrombin receptor antagonists
09/20/2007US20070219372 Novel Amination Process
09/20/2007US20070219266 N-Acylated-3-(Benzoyl)-Pyrrolidines as 11-Beta-HSD1 Inhibitors Useful for the Treatment of Metabolic Disorders
09/20/2007US20070219254 Therapeutic Compounds: Pyridine N-Oxide Scaffold
09/20/2007US20070219210 Amidopyrazole Derivative
09/20/2007US20070219203 Arylalkylamino-substituted quinazoline analogues
09/20/2007US20070219197 Pyridyl alkene and pyridyl alkine- acid amides as cytostatics and immuno-suppressives
1 ... 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 ... 694